| Name | Bel Aire Center |
|---|---|
| Location | 35 Bel-aire Drive, Newport, Vermont |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 44 |
| Occupancy Rate | 112.27% |
| Medicare ID (CCN) | 475049 |
| Legal Business Name | Thirty Five Bel-aire Drive Snf Operations Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1851573240 |
| Organization Name | THIRTY FIVE BEL-AIRE DRIVE SNF OPERATIONS LLC |
| Doing Business As | BEL-AIRE CENTER |
| Address | 35 Bel Aire Dr, Newport, VT 05855 |
| Phone Number | 802-334-2878 |
News Archive
Researchers from the University of Auckland, New Zealand, have discovered that a potent new drug restores hearing after noise-induced hearing loss in rats. The landmark discovery found that injection of an agent called 'ADAC', activates adenosine receptors in cochlear tissues, resulting in recovery of hearing function. The finding paves the way for effective non-surgical therapies to restore hearing loss after noise-induced injury. Dr. Srdjan Vlajkovic and his team's work1 is published in a special edition of Springer's journal Purinergic Signalling, focusing on the inner ear.
Professor Sanjeev Krishna and colleagues at St George's, University of London are heading a consortium that has been awarded EUR3.75 million to develop a treatment for one of the world's most neglected tropical diseases, leishmaniasis.
A new three-year contract launched in Adelaide today will see the Drug and Therapeutics Information Service based at the Repatriation General Hospital continue to deliver NPS MedicineWise educational visiting programs to general practitioners (GPs) across South Australia.
LSTM has been awarded £11 million by the National Institute for Health Research as part of their latest UK-wide call for funding into Global Health Research Units.
The East African examines the Climate Change, Agriculture and Food Security program, a 10-year research collaboration between the Consultative Group on International Agriculture Research and the Earth System Science Partnership that aims to help rural communities address these issues (Butunyi, 5/24).
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Researchers from the University of Auckland, New Zealand, have discovered that a potent new drug restores hearing after noise-induced hearing loss in rats. The landmark discovery found that injection of an agent called 'ADAC', activates adenosine receptors in cochlear tissues, resulting in recovery of hearing function. The finding paves the way for effective non-surgical therapies to restore hearing loss after noise-induced injury. Dr. Srdjan Vlajkovic and his team's work1 is published in a special edition of Springer's journal Purinergic Signalling, focusing on the inner ear.
Professor Sanjeev Krishna and colleagues at St George's, University of London are heading a consortium that has been awarded EUR3.75 million to develop a treatment for one of the world's most neglected tropical diseases, leishmaniasis.
A new three-year contract launched in Adelaide today will see the Drug and Therapeutics Information Service based at the Repatriation General Hospital continue to deliver NPS MedicineWise educational visiting programs to general practitioners (GPs) across South Australia.
LSTM has been awarded £11 million by the National Institute for Health Research as part of their latest UK-wide call for funding into Global Health Research Units.
The East African examines the Climate Change, Agriculture and Food Security program, a 10-year research collaboration between the Consultative Group on International Agriculture Research and the Earth System Science Partnership that aims to help rural communities address these issues (Butunyi, 5/24).
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $7345 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.84 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 0.71 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 56.52 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.64 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.38 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 7.5 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.5 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.53 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 88.24 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 33.1 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 2.13 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 69.71 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 95.05 | 82.93 |
News Archive
Researchers from the University of Auckland, New Zealand, have discovered that a potent new drug restores hearing after noise-induced hearing loss in rats. The landmark discovery found that injection of an agent called 'ADAC', activates adenosine receptors in cochlear tissues, resulting in recovery of hearing function. The finding paves the way for effective non-surgical therapies to restore hearing loss after noise-induced injury. Dr. Srdjan Vlajkovic and his team's work1 is published in a special edition of Springer's journal Purinergic Signalling, focusing on the inner ear.
Professor Sanjeev Krishna and colleagues at St George's, University of London are heading a consortium that has been awarded EUR3.75 million to develop a treatment for one of the world's most neglected tropical diseases, leishmaniasis.
A new three-year contract launched in Adelaide today will see the Drug and Therapeutics Information Service based at the Repatriation General Hospital continue to deliver NPS MedicineWise educational visiting programs to general practitioners (GPs) across South Australia.
LSTM has been awarded £11 million by the National Institute for Health Research as part of their latest UK-wide call for funding into Global Health Research Units.
The East African examines the Climate Change, Agriculture and Food Security program, a 10-year research collaboration between the Consultative Group on International Agriculture Research and the Earth System Science Partnership that aims to help rural communities address these issues (Butunyi, 5/24).
› Verified 5 days ago